StonvexLoading…
StonvexCore line items from ORKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $4.42M | $2.96M |
Operating Income | $-5.81M | $-6.36M |
Net Income | $-3.48M | $-6.33M |
EPS (Diluted) | $-0.60 | $-0.30 |
Total Assets | $9.22M | $11.72M |
Total Liabilities | $2.59M | $1.80M |
Cash & Equivalents | $2.32M | $5.98M |
Free Cash Flow OCF − CapEx | $-3.84M | $-7.28M |
Shares Outstanding | 5.84M | 5.84M |